News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
708,908 Results
Type
Article (54692)
Company Profile (223)
Press Release (653966)
Multimedia
Podcasts (123)
Webinars (24)
Section
Business (186820)
Career Advice (2757)
Deals (33628)
Drug Delivery (140)
Drug Development (85817)
Employer Resources (157)
FDA (17462)
Job Trends (14704)
News (331918)
Policy (33243)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2857)
Academic (1)
Accelerated approval (48)
Adcomms (38)
Allergies (178)
Alliances (50056)
ALS (217)
Alzheimer's disease (1892)
Antibody-drug conjugate (ADC) (469)
Approvals (17772)
Artificial intelligence (709)
Autoimmune disease (291)
Automation (55)
Bankruptcy (347)
Best Places to Work (11686)
BIOSECURE Act (22)
Biosimilars (224)
Biotechnology (158)
Bladder cancer (190)
Brain cancer (79)
Breast cancer (779)
Cancer (5990)
Cardiovascular disease (500)
Career advice (2347)
Career pathing (45)
CAR-T (342)
CDC (64)
Celiac Disease (3)
Cell therapy (925)
Cervical cancer (48)
Clinical research (74369)
Collaboration (2137)
Company closure (7)
Compensation (1172)
Complete response letters (95)
COVID-19 (2898)
CRISPR (111)
C-suite (1147)
Cystic fibrosis (159)
Data (7821)
Decentralized trials (3)
Denatured (44)
Depression (181)
Dermatology (81)
Diabetes (596)
Diagnostics (7024)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (38)
Drug discovery (337)
Drug pricing (212)
Drug shortages (32)
Duchenne muscular dystrophy (297)
Earnings (74826)
Editorial (71)
Employer branding (19)
Employer resources (143)
Events (105349)
Executive appointments (1130)
FDA (21253)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (35)
Funding (1777)
Gene editing (243)
Generative AI (69)
Gene therapy (755)
GLP-1 (1102)
Government (5000)
Grass and pollen (8)
Guidances (406)
Healthcare (19500)
HIV (81)
Huntington's disease (59)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (100)
Immunology and inflammation (310)
Immuno-oncology (98)
Indications (180)
Infectious disease (3250)
Inflammatory bowel disease (232)
Inflation Reduction Act (12)
Influenza (140)
Intellectual property (291)
Interviews (521)
IPO (15941)
IRA (47)
Job creations (3340)
Job search strategy (1910)
JPM (62)
Kidney cancer (21)
Labor market (85)
Layoffs (568)
Leadership (47)
Legal (7180)
Liver cancer (103)
Longevity (29)
Lung cancer (783)
Lymphoma (432)
Machine learning (61)
Management (56)
Manufacturing (1020)
MASH (196)
Medical device (13601)
Medtech (13705)
Mergers & acquisitions (18909)
Metabolic disorders (1537)
mRNA (214)
Multiple sclerosis (195)
NASH (21)
Neurodegenerative disease (444)
Neuropsychiatric disorders (115)
Neuroscience (3481)
Neurotech (1)
NextGen: Class of 2026 (6793)
Non-profit (4929)
Now hiring (57)
Obesity (712)
Opinion (355)
Ovarian cancer (220)
Pain (262)
Pancreatic cancer (300)
Parkinson's disease (376)
Partnered (37)
Patents (591)
Patient recruitment (693)
Peanut (63)
People (57657)
Pharmaceutical (47)
Pharmacy benefit managers (32)
Phase 1 (23490)
Phase 2 (32734)
Phase 3 (24209)
Pipeline (8342)
Policy (333)
Postmarket research (2611)
Preclinical (9626)
Press Release (60)
Prostate cancer (307)
Psychedelics (64)
Radiopharmaceuticals (339)
Rare diseases (1139)
Real estate (5621)
Recruiting (71)
Regulatory (26653)
Reports (39)
Research institute (2680)
Resumes & cover letters (453)
Rett syndrome (36)
RNA editing (21)
RSV (88)
Schizophrenia (187)
Series A (299)
Series B (222)
Service/supplier (9)
Sickle cell disease (114)
Special edition (28)
Spinal muscular atrophy (182)
Sponsored (50)
Startups (3602)
State (2)
Stomach cancer (20)
Supply chain (125)
Tariffs (84)
The Weekly (78)
Vaccines (1161)
Venture capital (111)
Weight loss (471)
Women's health (125)
Worklife (22)
Date
Today (196)
Last 7 days (850)
Last 30 days (3167)
Last 365 days (30763)
2026 (11472)
2025 (30674)
2024 (35240)
2023 (39933)
2022 (50988)
2021 (55400)
2020 (54145)
2019 (47528)
2018 (36102)
2017 (32776)
2016 (31799)
2015 (36878)
2014 (29197)
2013 (24682)
2012 (26183)
2011 (26914)
2010 (25315)
Location
Africa (924)
Alabama (96)
Alaska (6)
Arizona (297)
Arkansas (15)
Asia (43141)
Australia (7532)
California (12722)
Canada (3657)
China (1379)
Colorado (554)
Connecticut (552)
Delaware (369)
Europe (96839)
Florida (1929)
Georgia (408)
Hawaii (3)
Idaho (63)
Illinois (1046)
India (88)
Indiana (582)
Iowa (22)
Japan (523)
Kansas (130)
Kentucky (53)
Louisiana (44)
Maine (84)
Maryland (1557)
Massachusetts (9136)
Michigan (361)
Minnesota (661)
Mississippi (7)
Missouri (146)
Montana (36)
Nebraska (28)
Nevada (143)
New Hampshire (87)
New Jersey (3397)
New Mexico (32)
New York (3388)
North Carolina (1620)
North Dakota (10)
Northern California (6322)
Ohio (388)
Oklahoma (26)
Oregon (44)
Pennsylvania (2532)
Puerto Rico (29)
Rhode Island (44)
South America (1210)
South Carolina (85)
South Dakota (2)
Southern California (5054)
Tennessee (205)
Texas (2093)
United States (45215)
Utah (378)
Vermont (1)
Virginia (320)
Washington D.C. (80)
Washington State (1024)
West Virginia (4)
Wisconsin (124)
Wyoming (2)
708,908 Results for "national institute for clinical excellence nice".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Galderma’s Nemluvio® (nemolizumab) Receives National Institute for Health and Care Excellence (NICE) Recommendation for Moderate-to-severe Atopic Dermatitis in England and Wales
June 12, 2025
·
9 min read
Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE) for its PICO Single Use Negative Pressure Wound Therapy System (sNPWT).
April 4, 2024
·
7 min read
Press Releases
Parker Institute for Cancer Immunotherapy Appoints Bolyn Hubby as Chief of Staff to Strengthen Organization Excellence During Period of Growth
March 27, 2026
·
3 min read
NICE Endorses Brainomix AI-Enabled Software in Stroke
The U.K. health assessor the National Institute of Health and Care Excellence (NICE) has issued guidance endorsing the use of Brainomix 360 (formerly known as e-Stroke) to help clinical decision making in stroke.
February 7, 2024
·
4 min read
Press Releases
National Organization for Rare Disorders Adds Seven Rare Disease Centers of Excellence Nationwide
December 4, 2025
·
3 min read
Press Releases
SK pharmteco Collaborates with Axle Informatics and the National Institutes of Health to Advance Rare Disease Gene Therapy Programs
May 7, 2026
·
3 min read
Press Releases
START Research Expands Clinical Leadership with Appointment of Dr. Neel Belani as Clinical Investigator at START New Jersey
Strengthening clinical research capabilities in one of the nation’s most densely populated and high-opportunity oncology markets
April 30, 2026
·
1 min read
Press Releases
Leading Parkinson’s Organizations Urge Congress to Preserve Progress and Strengthen Parkinson’s Research Funding at the National Institutes of Health
April 5, 2026
·
4 min read
Press Releases
Formosa Pharmaceuticals and Singapore Eye Research Institute (SERI) Partner to Advance Novel Ophthalmic Formulations for Corneal Diseases
April 30, 2026
·
3 min read
BioCapital
UK’S National Institute for Health and Care Excellence (NICE) Selects CEL-SCI’s Multikine as Potential New Standard of Care for Head & Neck Cancer
CEL-SCI Corporation announced that the British National Institute for Health and Care Excellence has selected Multikine* to be evaluated as the potential new standard of care for squamous cell carcinoma of the head and neck in the UK.
December 4, 2023
·
5 min read
1 of 70,891
Next
